logo
logo

Sanofi Names Houman Ashrafian As R&D Chief, Appoints Head of Business Operations, Chief Digital Officer

Aug 31, 2023almost 2 years ago

Position

Vice President

Company

Sanofi

Houman Ashrafian
ParisPharmaceuticalMedicalBiotechnologyHealth Care

Description

Houman Ashrafi­an, cur­rent­ly a man­ag­ing part­ner at SV, will start his new role in Sep­tem­ber, join­ing sev­er­al new mem­bers of Sanofi’s ex­ec­u­tive com­mit­tee. Em­manuel Frene­hard, now glob­al head of dig­i­tal, has been pro­mot­ed to chief dig­i­tal of­fi­cer. Bri­an Foard will take over the spe­cial­ty care glob­al busi­ness unit on an in­ter­im ba­sis, as Bill Si­bold leaves the com­pa­ny to pur­sue a new op­por­tu­ni­ty.

Company Information

Company

Sanofi

Location

Paris, Texas, United States

About

LONDON--(BUSINESS WIRE)--Gyroscope Therapeutics Holdings plc (Gyroscope), a clinical-stage gene therapy company focused on diseases of the eye, today announced that Sanofi, a global biopharmaceutical company, has committed to invest up to USD $60.0 million (GBP £44.5 million) in equity in Gyroscope.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months